How vaccine laggard CureVac hopes to come out on top

A transatlantic tug of love and a CEO brain haemorrhage afflicted the Bill Gates-backed biotech
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news